Correlation Between Spruce Biosciences, and Coeptis Therapeutics
Can any of the company-specific risk be diversified away by investing in both Spruce Biosciences, and Coeptis Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spruce Biosciences, and Coeptis Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spruce Biosciences, Common and Coeptis Therapeutics, you can compare the effects of market volatilities on Spruce Biosciences, and Coeptis Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spruce Biosciences, with a short position of Coeptis Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spruce Biosciences, and Coeptis Therapeutics.
Diversification Opportunities for Spruce Biosciences, and Coeptis Therapeutics
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Spruce and Coeptis is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Spruce Biosciences, Common and Coeptis Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coeptis Therapeutics and Spruce Biosciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spruce Biosciences, Common are associated (or correlated) with Coeptis Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coeptis Therapeutics has no effect on the direction of Spruce Biosciences, i.e., Spruce Biosciences, and Coeptis Therapeutics go up and down completely randomly.
Pair Corralation between Spruce Biosciences, and Coeptis Therapeutics
Given the investment horizon of 90 days Spruce Biosciences, Common is expected to generate 7.19 times more return on investment than Coeptis Therapeutics. However, Spruce Biosciences, is 7.19 times more volatile than Coeptis Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Coeptis Therapeutics is currently generating about 0.1 per unit of risk. If you would invest 2,915 in Spruce Biosciences, Common on September 12, 2025 and sell it today you would earn a total of 5,652 from holding Spruce Biosciences, Common or generate 193.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spruce Biosciences, Common vs. Coeptis Therapeutics
Performance |
| Timeline |
| Spruce Biosciences, |
| Coeptis Therapeutics |
Spruce Biosciences, and Coeptis Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spruce Biosciences, and Coeptis Therapeutics
The main advantage of trading using opposite Spruce Biosciences, and Coeptis Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spruce Biosciences, position performs unexpectedly, Coeptis Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will offset losses from the drop in Coeptis Therapeutics' long position.| Spruce Biosciences, vs. NRX Pharmaceuticals | Spruce Biosciences, vs. Werewolf Therapeutics | Spruce Biosciences, vs. OUTLOOK THERAPEUTICS INC | Spruce Biosciences, vs. IO Biotech |
| Coeptis Therapeutics vs. Equillium | Coeptis Therapeutics vs. Century Therapeutics | Coeptis Therapeutics vs. Cue Biopharma | Coeptis Therapeutics vs. NRX Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |